Influenza vaccines Vaccine safety data Main navigation COVID-19 vaccines Influenza vaccines 6 months to younger than 5 years 5 years and older (standard vaccines) 60 years and older (adjuvanted or high-dose vaccine) Pregnant participants Aboriginal and Torres Strait Islander participants (all ages) Mpox (monkeypox) vaccine National Immunisation Program schedule vaccines Nirsevimab RSV vaccines Shingrix AusVaxSafety commenced routine safety monitoring of 2025 seasonal influenza vaccines used in Australia across all ages in March 2025.The influenza vaccines in use in Australia in 2025 are:Standard influenza vaccinesAfluria Quad (individuals aged 5 years and older)Flucelvax Quad (individuals aged 6 months and older)FluQuadri (individuals aged 6 months and older)Influvac Tetra (individuals aged 6 months and older)Vaxigrip Tetra (individuals aged 6 months and older).Adjuvanted or high-dose vaccinesFluad Quad (individuals aged 65 years and over)Fluzone High-Dose (individuals aged 60 years and over).Surveillance data are gathered via AusVaxSafety surveillance tools and are based on vaccine safety surveys sent in the days following influenza vaccination. Latest influenza vaccine safety dataClick on the tiles below to view 2025 AusVaxSafety influenza vaccine safety data for specific age and population groups. Influenza vaccine safety data – 6 months to younger than 5 years View the latest safety data here Influenza vaccine safety data – 5 years and older (standard vaccines) View the latest safety data here Influenza vaccine safety data – 60 years and older (adjuvanted or high-dose vaccine) View the latest safety data here Influenza vaccine safety data – pregnant participants View the latest safety data here Influenza vaccine safety data – Aboriginal and Torres Strait Islander participants (all ages) View the latest safety data here Vaccine safety data Main navigation COVID-19 vaccines Influenza vaccines 6 months to younger than 5 years 5 years and older (standard vaccines) 60 years and older (adjuvanted or high-dose vaccine) Pregnant participants Aboriginal and Torres Strait Islander participants (all ages) Mpox (monkeypox) vaccine National Immunisation Program schedule vaccines Nirsevimab RSV vaccines Shingrix News & events All news & events 14 July 2025 | News Fewer adverse events reported following NIP pneumococcal vaccine change 03 June 2025 | News New AusVaxSafety data confirms Abrysvo RSV vaccine is well tolerated during pregnancy; adverse events comparable to other maternal vaccinations 18 May 2025 | News 2025 Australian flu season: Who should get a flu shot, which vaccines are available and what to expect in the days following your vaccination 31 March 2025 | News AusVaxSafety commences routine surveillance of 2025 seasonal influenza vaccines